|  |  |  | | | | | PR Newswire: Health | | | | | | | | |  |  |  | | | | | | | | ESTOCOLMO, 10 de noviembre de 2010 /PRNewswire/ -- Un nuevo estudio muestra que los L. reuteri Prodentis actúan de forma sinérgica con el tratamiento estándar (decapado y alisado radicular, SRP, por sus siglas en inglés) para reducir significativamente la profundidad de sondaje d
| | | | | | | | | | | | | | |  |  |  | | | | | | | | ESTOCOLMO, 10 de novembro de 2010 /PRNewswire/ -- O estudo mostra que o L. reuteri Prodentis age sinergisticamente com o tratamento padrão (raspagem tradicional e regularização da raiz, SRP) reduzindo significativamente a profundidade da cavidade para sondagem (PPD) e nível cl
| | | | | | | | | | | | | | |  |  |  | | | | | | | | STOCKHOLM, November 10, 2010 /PRNewswire-FirstCall/ -- The study shows that L. reuteri Prodentis acts synergistically with standard treatment (scaling and root plaining, SRP) to significantly reduce probing pocket depth (PPD) and clinical attachment level (CAL) which are the two most important p
| | | | | | | | | | | | | | |  |  |  | | | | | | | | LONDON, Nov. 10, 2010 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces positive research findings demonstrating the ability of the Company's lead RNA interference (RNAi) drug candidate, Atu027, to prevent the formation of pulmonary metastasis in various anim | | | | | | | | | | | | | | |  |  |  | | | | | | | | BASEL, Switzerland and WILMINGTON, Del., Nov. 10, 2010 /PRNewswire-FirstCall/ -- Syngenta and DuPont today announced that Syngenta has assumed full ownership of GreenLeaf Genetics, LLC, effective November 8, 2010. The transaction dissolves a joint venture between Syngenta Seeds, Inc. and DuPont busi | | | | | | | | | | | | | | |  |  |  | | | | | | | | CHENGDU, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will attend Brean Murr | | | | | | | | | | | | | | |  |  |  | | | | | | | | NEW YORK, Nov. 9, 2010 /PRNewswire/ -- See Still Image from Cipla at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=7d84d552-15c1-4161-bc08-40a209cf6c99 Cipla, one of the world's leading generic pharmaceutical companies is the first from India to get The Australian Pesticides and Ve | | | | | | | | | | | | | | |  |  |  | | | | | | | | DALLAS, Nov. 9, 2010 /PRNewswire/ -- Entrust, Inc. President and CEO Bill Conner addressed global security and law enforcement leaders during INTERPOL's 79th General Assembly in Doha, Qatar, Monday. With many dignitaries, officials and ministers in attendance, Conner explained the current identity f
| | | | | | | | | | | | | | |  |  |  | | | | | | | | DOHA, Qatar, DALLAS and KIEV, Ukraine, Nov. 9, 2010 /PRNewswire/ -- ENTRUST, the U.S. company that provides identity-based security solutions for nine of the top 10 global e-governments, partnered with EDAPS, the Ukrainian consortium of high-tech companies, to provide INTERPOL with unprecedented, hi
| | | | | | | | | | | | | | |  |  |  | | | | | | | | HONG KONG, Nov. 9, 2010 /PRNewswire-Asia/ -- Shandong Luoxin Pharmacy Stock Co., Ltd. ("Luoxin Pharma" or the "Company", stock code: 8058), one of the leading PRC pharmaceutical enterprises, announced its results for the nine months ended 30 September 2010 ("the period under review") today, reco | | | | | | | | | | | | | | |  |  |  | | | | | | | | PITTSBURGH, Nov. 9, 2010 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced the pricing in the private placement of senior notes announced earlier today. Mylan priced $800 million aggregate principal amount of 6.0% Senior Notes due 2018 at an issue price of 98.450%. Mylan | | | | | | | | | | | | | | |  |  |  | | | | | | | | INDEPENDENCE, Mo., Nov. 9, 2010 /PRNewswire/ -- Outreach International, a humanitarian organization based in Greater Kansas City, Missouri, announces its 2010 holiday shopping solution. For the person who has everything, the new Sustainable Gifts Catalog is filled with meaningful gifts that make a l | | | | | | | | | | | | | | |  |  |  | | | | | | | | NEW YORK, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), (the "Company" or "AOB"), a pharmaceutical company dedicated to improving healthcare through the development, manufacture and commercialization of a broad range of prescription and over-the-coun | | | | | | | | | | | | | | |  |  |  | | | | | | | | WHITE PLAINS, Nueva York, 9 de noviembre del 2010 /PRNewswire-HISPANIC PR WIRE/ -- Doctores y pacientes deben conversar sobre el riesgo que presenta una embarazada de parto prematuro en la décimo segunda semana del embarazo, según un comentario publicado en la edición de noviembre de | | | | | | | | | | | | | | |  |  |  | | | | | | | | 2nd annual report based on more than 1,500 postmarketing studies, clinical trials SILVER SPRING, Md., Nov. 9, 2010 /PRNewswire-USNewswire/ -- Most makers of approved drug and biological products are meeting their regulatory obligations and meeting targets for postmarketing studies/clinical trials in
| | | | | | | | |  |  |  |  |  | |
No comments:
Post a Comment